
Wednesday, February 05, 2025 8:38:43 AM
Recent ACET News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2025 08:09:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2025 08:05:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2025 08:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2025 08:02:01 PM
- Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference • Business Wire • 05/21/2025 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2025 08:07:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 08:04:06 PM
- Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates • Business Wire • 05/06/2025 08:01:00 PM
- Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/30/2025 08:47:00 PM
- Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference • Business Wire • 04/30/2025 11:00:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2025 08:11:02 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2025 08:09:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2025 08:07:46 PM
- Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting • Business Wire • 04/28/2025 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2025 08:11:32 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2025 08:09:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2025 11:02:30 AM
- Adicet Bio Appoints Michael Grissinger to the Board of Directors • Business Wire • 04/17/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/11/2025 08:01:56 PM
- Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/31/2025 09:12:00 PM
- Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference • Business Wire • 03/31/2025 11:00:00 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/26/2025 08:31:56 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/18/2025 08:02:52 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/06/2025 09:58:02 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM